Probiotic candidate L. reuteri was screened out for in vivo experiments based on a 19 relatively higher gastrointestinal tolerance and moderate adhesiveness. As results 20 shown in in-vivo experiments, a significantly higher level of IL-12 at low-dose group 21 was found both in females and males. Higher levels of T-lymphocytes were also 22 observed in females compared to control group, however, males displayed a reduction 23 expcept for CD8-positive cells in ileum. In comparison to the control group, the 24 relative abundance of phylotypes in the phylum Bacteroidetes (genus of Bacteroides, 25 Prevotella) and Firmicutes (genus of ClostridiumIV) exihibited a reserve shift 26 between sexes after L. reuteri intervened. Meanwhile, the relative abundance of 27 several taxa (Acetobacteroides, Lactobcaillus, bacillus) also differed markedly in 28 sexes at low-dose group, together with microbiota diversity, as indicated by Shannon 29 index. 30 31 Importance 32 Sexual dimorphism has triggered researchers' attention. However, the relationship 33 between immune parameters and gut microbiota caused by Lactobacillus at different 34 dosage are not fully elucidated. In present research, the possible probiotic role of L. 35 reuteri DMSZ 8533 on immunomodulation and effect on fecal microbiota 36 composition were investigated. Our findings demonstrate the importance of L. reuteri 37 DMSZ 8533 as a potential probiotic strain with an immunomodulatory effect, which 38 also alters the microflora composition depending on the sex of the host.
Introduction 62
Lactobacillus, which are generally considered probiotic, are the resident microflora in 63 the human gastrointestinal tract (GIT). They exhibit various health-promoting effects, 64 including anti-cancer [1, 2] and anti-oxidation [3] effects, while helping to maintain 65 microflora balance [4] and assisting in immuno-regulation [5] . Many Lactobacillus 66 species are considered safe (GRAS) [6] and food-grade. They are involved in the 67 fermentation of food such as in dry-fermented sausage [7] and yoghurt [8] among 68 others. 69 To exert beneficial effects on a host, Lactobacillus must survive in, and colonize, 70 the human GIT. Therefore, a high tolerance to low pH and bile toxicity are 71 indispensable for achieving any potential probiotic effects [9, 10] . Some Lactobacillus 72 have survived in an adequate dose after passing through the human GIT in vitro. 73 However, some strains displayed poor survival [11, 5] . Adhesion ability is a key 74 criteria, which has mainly been evaluated by performing in vitro experiments 75 [12, 13, 14, 15] . The HT-29 and Caco-2 cell lines are widely accepted models for the 76 evaluation of bacterial adherence due to the fact that their morphological and 77 functional properties mimic those of mature enterocytes [16] . 78 Oral treatment with Lactobacillus has been shown to enhance immune response at 79 the systemic [17, 18] and mucosal [19] levels. Interaction between Lactobacillus and 80 the intestinal mucosal system exerts vital effects on gut-associated immunoglobulin 81 secretion, and on CD4 and CD8 T-lymphocyte activation [20] . Furthermore, 82 Lactobacilli stimulate CD4-positive cells [21] , which can differentiate into T helper 83 5 type 1 or 2 (Th1/Th2) lymphocytes. Th1 cells mainly mediate cellular immunity 84 associated with the cytokines Interferon-γ and TNF-α, while Th2 cells drive the 85 humoral immune response by secreting IL-4 and IL-5. However, the 86 Lactobacillus-influenced immunomodulatory effect is strain-specific [22, 23] , and also 87 is related to the concentration of Lactobacillus [24] . 88 In addition to immune effects, the ingestion of " values ranging from 20.40% to 26.03% (Fig. 1B) . However, no significant difference 111 (P > 0.05) was found among tested strains. The percentage of cell surface 112 hydrophobicity for L. plantarum, L. acidophilus and L. reuteri was significantly 113 different (P >0.05), and L. reuteri was characterized by the highest affinity to xylene 114 and a modest adhesion value (3.82%). However, L. plantarum and L. acidophilus both 115 exhibited low cell surface hydrophobic values (less than 20%) and limited adhesive 116 values ( Fig. 1C and 1D ). Table 1 shows, 118 treatment with a low dose of L. reuteri significantly decreased the spleen index 119 compared with males in the high-dose group, although there was a slight increase 120 observed in females. L. reuteri treatment (low-and high-dose groups) significantly 121 decreased the thymus index compared with control group males, while there was no 122 significant difference among females in the groups. Treatment with high doses of L. (Table S1 ). For Alpha diversity analysis (Table S2) , high-dose of L. reuteri 149 8 significantly reduced shannon index compared with low-dose group in males, together 150 with an apparent difference between sex (Table S3 ). While no apparent difference 151 found in females. Based on beta diversity analysis, UniFirac clustering analysis 152 suggested that there were no obvious phylogenetic differences and similar community 153 structure between the control and high-dose groups in females ( Fig. 6A ). However, 154 the control group results clustered together more closely with males in the low-dose 155 group (Fig. 6B ).
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Organ mass and Cytokine Measurement in BALB/c mice As
156
Sex difference on microflora richness at taxonomic level Taxonomic assignment 157 at the phylum level indicated that gut microbiota shared a similar structure in female 158 and male subjects consisting of four major phyla: Bacteroidetes, Firmicutes, 159 Proteobacteria, and Actinobacteria. As Table 2 shows, a constant decline in the 160 abundance of Actinobacteria in females was also found in males, but there was a 161 statistically significant sharp decrease in females in the high-dose group. Additionally, relationship. What' more, an apparent difference was found between sexes at 170 low-dose group (Table S4 ). An Ascend trend was found in high-dose group of 9 females in relation to Lactococcus abundance while a decrease in males.
172
Discussion
173
Tolerance to the stressful conditions found in the GIT and adherence to epithelial cells 174 are commonly believed to be key factors in identifying probiotics [31] . The pH in the 175 human stomach is approximately 2.0 to 2.5 [32] and the bile content in the upper 176 small intestine ranges from 0.3% to 0.5% [33, 34] , which can destroy Lactobacillus 177 and the attendant potential probiotic characteristics. Adhesion is another essential 178 criterion to select a potential probiotic strain, since it is related to the residence time of 179 Lactobacillus and, possibly, temporal colonization [35] . In our study, L. reuteri 180 displayed promising survival rate and adhesion ability values, which is consistent with 181 another study [36] . Based on these results, we conducted in vivo experiments to 182 evaluate the effect of this possibly probiotic L. reuteri strain on immune response and 183 microflora diversity. 184 Recently, mocusal immunity mediated by L. reuteri has sparked increased interest 185 among researchers [37, 38] . T lymphocytes initiate their helper or cytotoxic roles 186 when they are activated by antigens or pathogens. In our study, low and high doses of 187 L. reuteri induced a considerable increase in the number of T lymphocytes in females, 188 which agreed with previous observations [37] . In contrast with changes in females, a 189 slight decline was obtained in CD4-and CD3-positive cells in males. We 190 hypothesized that the difference was due to sex hormones, such as estrogen or 191 17ß-estradio (E2), which are widely accepted as enhancers of CD4 + T cell expansion 192 [39, 40] . In mice, there are at least three CD4 + subsets: Th1, Th2 and Th0. Th1 mainly 193 10 mediate cellular immunity associated with the secretion of the cytokines IL-12, and TNF-α. IL-12, produced by cells as part of the innate defense system in response 195 to bacteria, is primarily IFN-γ [41] . Low doses of L. reuteri were the most significant 196 inducer of IL-12 in males and females, confirming that L. reuteri possess potent 197 immune-enhancing properties. Our findings were consistent with other findings [42] . 198 However, high doses of L. reuteri had no effect on IL-12 secretion compared with the 199 control group, which also agreed with previous research [43] that Lactobacillus were 200 active only at low-bacterial concentrations. This finding might be ascribed to low and 201 high dose microbe-associated molecular patterns (MAMP) mediating different 202 receptor conformations, or they may differentially distribute to subcellular locations, 203 subsequently activating different downstream pathways [44] . We further investigated 204 the level of TNF-ɑ, a major pro-inflammatory cytokine that can mediate the 205 inflammatory response at a systemic level [45] . Notably, concentrations of TNF-α in 206 males was much higher than that found in females. The higher content of 207 Helicobacter and Escherichia in males (Table 2) Bacteria in the stationary phase were centrifuged (6000×g, 10 min), washed twice and 295 re-suspended in PBS adjusted to OD 600 =0.7±0.05. Then they were mixed with 10 μM 296 6-carboxyfluorescein diacetate (CFDA; Sigma, Darmstadt, Germany) and incubated 297 at 37 ℃ for 30 min. Bacteria were washed three times to remove any unmarked 298 CFDA. Caco-2-coated wells were washed twice with PBS, and 2 mL of 299 CFDA-labelled bacteria were added. The mixture was incubated in a 5% CO2 300 atmosphere at 37 ℃ for 2 h. After incubation, the wells were washed three times with 301 2 mL PBS to remove the un-adhered bacteria, and then 1.4 mL 0.25% EDTA-trypsin 302 was added into the wells for 10 min. Then 0.6 mL DMEM was added to terminate Blood drawn from the eyes was collected, kept at room temperature for 1.5 h and 326 centrifuged (2500×g, 30 min). The obtained serum was frozen (-80 ℃) for IL-12 and 327 TNF-ɑ determination using a mouse IL-12/TNF-ɑ Elisa Kit (Lianke-Biotech Co., 328 Hangzhou, China). [8] Jankovic, I., Sybesma, W., Phothirath, P., Ananta, E., Mercenier, A., 2010. 412 Application of probiotics in food products-challenges and new approaches. Curr Opin 413 Biotech. 21: 175-181.
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